The influenza vaccines market in Middle East & Africa is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Strong Pipeline Candidates for Influenza Vaccines

Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats.

Market Overview

The Middle East & Africa Influenza Vaccines Market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. In 2021, South Africa was the largest market for Influenza Market in the region. The market for Influenza Market in the Middle East & Africa is anticipated to grow at a CAGR of 6.1% during the forecast period The influenza vaccines market is expected to grow due to the huge population base, increasing cases of influenza, and growing research studies across the region. Moreover, growing healthcare facilities help propel the market growth. Saudi Arabia is one of the important countries in the Middle Eastern region that has significant scope for the influenza vaccines market. The healthcare system in the country is developing at a rapid pace as well as increasing number of international companies are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to drive the growth of the influenza vaccines market in the country.

Saudi Arabia is among the fastest growing regions in the Middle East & Africa whose growth is driven by a huge population base with chronic diseases. According to the latest WHO data published in 2020 Influenza and Pneumonia Deaths in Saudi Arabia reached 6,132 or 4.58% of total deaths. The age-adjusted Death Rate is 30.87 per 100,000 of population ranks Saudi Arabia 82 in the world. In 2009, in response to the pandemic Influenza A(H1N1)pdm09, the public health department at the Ministry of Health in Saudi Arabia established its first case-based Influenza surveillance system. In Saudi Arabia, rising healthcare spending and well-established hospital and tertiary care centers fuel the growth of the market. The government has increased healthcare and social affairs expenditure by 48% to US$ 42.64 billion (SR160bn) for the development of new healthcare centers, hospitals, and primary care centers. Thus, such initiatives by the government, and penetration of international market players are expected to drive the growth of influenza vaccines market in Saudi Arabia.

Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Influenza Vaccines Market Segmentation

The Middle East & Africa Influenza Vaccines Market is segmented into vaccine type, virus type, technology, route of administration, and country.

Based on vaccine type, the Middle East & Africa influenza vaccines market is divided into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered the larger market share in 2022.

Based on virus type, the Middle East & Africa influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger market share in 2022.

Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger market share in 2022.

Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger market share in 2022.

Based on country, the market is segmented into the UAE, Saudi Arabia, South Africa, and the rest of Middle East & Africa. Saudi Arabia dominated the market share in 2022.

AstraZeneca; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in Middle East & Africa.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Influenza Vaccines Market – By Vaccine Type
1.3.2 MEA Influenza Vaccines Market – By Virus Type
1.3.3 MEA Influenza Vaccines Market – By Technology
1.3.4 MEA Influenza Vaccines Market – By Route Of Administration
1.3.5 MEA Influenza Vaccines Market – By Country
2. MEA Influenza Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Influenza Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market – MEA Analysis
6.1 MEA Influenza Vaccines Market Revenue Forecasts And Analysis
7. MEA Influenza Vaccines Market– By Vaccine Type
7.1 Overview
7.2 MEA Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. MEA Influenza Vaccines Market– By Virus Type
8.1 Overview
8.2 MEA Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. MEA Influenza Vaccines Market – By Technology
9.1 Overview
9.2 MEA Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-Based
9.3.1 Overview
9.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-Based
9.4.1 Overview
9.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. MEA Influenza Vaccines Market– By Route of Administration
10.1 Overview
10.2 MEA Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. MEA Influenza Vaccines Market – Country Analysis
11.1 MEA Influenza Vaccine Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 MEA: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
11.1.2.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
11.1.2.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
11.1.2.1.4 Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
11.1.2.2 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
11.1.2.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
11.1.2.2.4 UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
11.1.2.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
11.1.2.3.4 South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
11.1.2.4 Rest of MEA: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 Rest of MEA: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 Rest of MEA: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
11.1.2.4.3 Rest of MEA: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
11.1.2.4.4 Rest of MEA: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
11.1.2.4.5 Rest of MEA: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12. MEA Influenza Vaccine Market –Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 SEQIRUS
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hualan Biological Engineering Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mitsubishi Chemical Group Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Serum Institute of India Pvt. Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MYLAN N.V.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AstraZeneca
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1.             MEA Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Table 2.             Saudi Arabia Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 3.             Saudi Arabia Influenza Vaccine Market, by Virus Type– Revenue and Forecast to 2028 (USD Million)
Table 4.             Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5.             Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 6.             UAE Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 7.             UAE Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 8.             UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 9.             UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 10.          South Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 11.          South Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 12.          South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 13.          South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14.          Rest of MEA Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 15.          Rest of MEA Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 16.          Rest of MEA Influenza Vaccine Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 17.          Rest of MEA Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 18.          Recent Inorganic Growth Strategies in the MEA Influenza Vaccine Market
Table 19.          Recent Organic Growth Strategies in the MEA Influenza Vaccine Market
Table 20.          Glossary of Terms, MEA Influenza Vaccines Market
 
 

LIST OF FIGURES

Figure 1.           MEA Influenza Vaccines Market Segmentation
Figure 2.           MEA Influenza Vaccines Market Segmentation, by Country
Figure 3.           MEA Influenza Vaccines Market Overview
Figure 4.           Quadrivalent Vaccines Segment Held Largest Share of Product Segment in MEA Influenza Vaccines Market
Figure 5.           Saudi Arabia Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7.           MEA: PEST Analysis
Figure 8.           Experts Opinion
Figure 9.           Impact Analysis
Figure 10.        MEA Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 11.        MEA Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 12.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14.        MEA Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 15.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17.        MEA Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 18.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20.        MEA Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 21.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22.        MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23.        MEA: Influenza Vaccine Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24.        MEA: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 25.        Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 26.        UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 27.        South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 28.        Rest of MEA: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Influenza Vaccines Market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Influenza Vaccines Market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Influenza Vaccines Market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

The List of Companies – Middle East & Africa Influenza Vaccines Market

● AstraZeneca
● GlaxoSmithKline plc.
● Hualan Biological Engineering Inc.
● Mitsubishi Chemical Group Corporation
● MYLAN N.V.
● Sanofi
● SEQIRUS
● Serum Institute of India Pvt. Ltd

At 6.1% CAGR, the Middle East & Africa Influenza Vaccines Market is speculated to be worth US$ 533.85 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Middle East & Africa influenza vaccines market was valued at US$ 374.35 million in 2022 and is expected to reach US$ 533.85 million by 2028, registering an annual growth rate of 6.1% from 2022 to 2028. The emerging economies and strong pipeline candidates for influenza vaccines are the critical factors attributed to the market expansion.

Leading players in the influenza vaccines market focus on expanding their customer reach across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in upgrading the latest technologies in developing countries. In turn, this supports the inclination toward advanced vaccine development. Key producers of influenza vaccines is expected to witness lucrative opportunities in the near future due to the large patient pool and high prevalence of influenza, improving healthcare infrastructure, rising disposable income, and the surge of medical tourism in these countries.

On the contrary, high cost of vaccine development hurdles the growth of Middle East & Africa influenza vaccines market.

Based on vaccine type, the Middle East & Africa influenza vaccines market is divided into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment held 90.3% market share in 2022, amassing US$ 338.19 million. It is projected to garner US$ 489.67 million by 2028 to expand at 6.4% CAGR during 2022–2028.

Based on virus type, the Middle East & Africa influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held 96.8% market share in 2022, amassing US$ 362.26 million. It is projected to garner US$ 519.40 million by 2028 to expand at 6.2% CAGR during 2022–2028.

Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held 77.9% market share in 2022, amassing US$ 291.46 million. It is projected to garner US$ 409.30 million by 2028 to expand at 5.8% CAGR during 2022–2028.

Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held 73.3% market share in 2022, amassing US$ 274.52 million. It is projected to garner US$ 399.18 million by 2028 to expand at 6.4% CAGR during 2022–2028.

Based on country, the Middle East & Africa influenza vaccines market is categorized into the UAE, Saudi Arabia, South Africa, and the rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 36.2% market share in 2022. It was assessed at US$ 135.40 million in 2022 and is likely to hit US$ 198.65 million by 2028, exhibiting a CAGR of 6.6% during the forecast period.

Key players dominating the Middle East & Africa influenza vaccines market are AstraZeneca; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd among others.